Significance of Dual-Tracer PET/CT-Guided Stereotactic Body Radiotherapy in Patients With Nonmetastatic Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodexyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study
Eur Urol Oncol 2022 Mar 15;[EPub Ahead of Print], J Pan, Y Wei, T Zhang, C Liu, X Hu, J Zhao, H Gan, W Liu, B Zhu, J Wu, B Wang, S Song, D Ye, Y ZhuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.